We are live on ! Find out more
DWA

Dorsey Wright & Associates Portfolio holdings

AUM $590M Turnover 51.79%
1-Year Est. Return 77.57%
This Fund
S&P 500
This Quarter Est. Return
+16.38%
1 Year Est. Return
+77.57%
3 Year Est. Return
+310.63%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$414M
AUM Growth
+$79.2M
Cap. Flow
+$38M
Cap. Flow %
9.19%
Top 10 Hldgs %
17.26%
Holding
356
New
91
Increased
48
Reduced
145
Closed
70
Avg Time Held
0.4 years
Top 10 Avg Time Held
0.3 years
Top 20 Avg Time Held
0.3 years

Top Buys

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$6.23M
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$5.69M
3
TDG icon
TransDigm Group
TDG
+$5.5M
4
GOL icon
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
+$4.34M
5
KEYS icon
Keysight
KEYS
+$4.16M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$8.84M
2
BA icon
Boeing
BA
+$7.79M
3
EC icon
Ecopetrol
EC
+$4.96M
4
HAE icon
Haemonetics
HAE
+$4.3M
5
RPM icon
RPM International
RPM
+$3.92M

Sector Composition

Rank Sector Weight
1 Technology 18.56%
2 Miscellaneous 15.98%
3 Healthcare 15.12%
4 Consumer Discretionary 8.06%
5 Industrials 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NSTG
151
DELISTED
NanoString Technologies, Inc.
NSTG
$14K ﹤0.01%
567
-564
-50% -$13K
2018 Q4
1 quarter
AUDC icon
152
AudioCodes
AUDC
$271M
$13K ﹤0.01%
926
-924
-50% -$12.2K
2018 Q3
2 quarters
LAB icon
153
Standard BioTools
LAB
$247M
$13K ﹤0.01%
968
-966
-50% -$10.2K
2018 Q4
1 quarter
MSB icon
154
Mesabi Trust
MSB
$235M
$13K ﹤0.01%
447
-447
-50% -$12.8K
2018 Q3
2 quarters
TPB icon
155
Turning Point Brands
TPB
$1.26B
$13K ﹤0.01%
279
-279
-50% -$10.7K
2018 Q3
2 quarters
KALV icon
156
DELISTED
KalVista Pharmaceuticals
KALV
$12K ﹤0.01%
433
-429
-50% -$9.3K
2018 Q4
1 quarter
OFG icon
157
OFG Bancorp
OFG
$2.22B
$12K ﹤0.01%
621
-621
-50% -$12K
2018 Q3
2 quarters
RARX
158
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$12K ﹤0.01%
542
-537
-50% -$11.5K
2018 Q4
1 quarter
REGI
159
DELISTED
Renewable Energy Group, Inc.
REGI
$12K ﹤0.01%
543
-543
-50% -$14K
2018 Q3
2 quarters
ATTU
160
DELISTED
Attunity Ltd
ATTU
$12K ﹤0.01%
524
-522
-50% -$11.6K
2018 Q3
2 quarters
AVTX icon
161
Avalo Therapeutics
AVTX
$604M
$11K ﹤0.01%
1
– –
2018 Q3
2 quarters
AXSM icon
162
Axsome Therapeutics
AXSM
$8.23B
$11K ﹤0.01%
+793
New +$7.36K
2019 Q1
0 quarters
KRYS icon
163
Krystal Biotech
KRYS
$9.37B
$11K ﹤0.01%
343
-342
-50% -$8.06K
2018 Q4
1 quarter
LFVN icon
164
LifeVantage
LFVN
$75.5M
$11K ﹤0.01%
754
-750
-50% -$10.9K
2018 Q3
2 quarters
MLAB icon
165
Mesa Laboratories
MLAB
$685M
$11K ﹤0.01%
46
-45
-49% -$10.2K
2018 Q3
2 quarters
QTNT
166
DELISTED
Quotient Limited Ordinary Shares
QTNT
$11K ﹤0.01%
30
-30
-50% -$10.6K
2018 Q3
2 quarters
SHSP
167
DELISTED
SharpSpring, Inc.
SHSP
$11K ﹤0.01%
714
-711
-50% -$10.2K
2018 Q3
2 quarters
OSIR
168
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$11K ﹤0.01%
597
-597
-50% -$9.68K
2018 Q4
1 quarter
ABR icon
169
Arbor Realty Trust
ABR
$502M
$10K ﹤0.01%
800
-760
-49% -$9.23K
2018 Q4
1 quarter
ADUS icon
170
Addus HomeCare
ADUS
$2.17B
$10K ﹤0.01%
159
-159
-50% -$10.2K
2018 Q3
2 quarters
AMRC icon
171
Ameresco
AMRC
$1.03B
$10K ﹤0.01%
642
-642
-50% -$10.1K
2018 Q3
2 quarters
CHEF icon
172
Chefs' Warehouse
CHEF
$4.63B
$10K ﹤0.01%
315
-315
-50% -$10.3K
2018 Q3
2 quarters
CLAR icon
173
Clarus
CLAR
$138M
$10K ﹤0.01%
783
-784
-50% -$8.84K
2018 Q4
1 quarter
DCO icon
174
Ducommun
DCO
$2.58B
$10K ﹤0.01%
228
-228
-50% -$9.36K
2018 Q4
1 quarter
ENPH icon
175
Enphase Energy
ENPH
$4.05B
$10K ﹤0.01%
+1,116
New +$8.49K
2019 Q1
0 quarters
5 6
7
8 9

Similar funds

AIM
Anatole Investment Management Central, Hong Kong $590M AUM 751.98% 1-Year Est. Return
ECM
Estuary Capital Management Wayzata, Minnesota $589M AUM 9.29% 1-Year Est. Return
DSC
Duncker Streett & Co St. Louis, Missouri $591M AUM 26.48% 1-Year Est. Return
SP
Solel Partners Boston, Massachusetts $588M AUM 14.47% 1-Year Est. Return
NWA
New World Advisors Hingham, Massachusetts $588M AUM 26.62% 1-Year Est. Return
TC
Triata Capital Hong Kong $588M AUM 8.92% 1-Year Est. Return
SIM
Studio Investment Management Chicago, Illinois $592M AUM 19.22% 1-Year Est. Return
FFA
Florida Financial Advisors Tampa, Florida $592M AUM 69.01% 1-Year Est. Return

Dorsey Wright & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Dorsey Wright & Associates held 356 positions worth $414M, up 24% from $334M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Dorsey Wright & Associates deployed $38M of net new capital in Q1 2019, opening 91 new positions and adding to 48 existing holdings. Its largest new stake was Zebra Technologies: 33,077 shares worth $6.93M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Boeing, an estimated $7.79M trimmed.

  • Dorsey Wright & Associates's largest Q1 2019 buy was Zebra Technologies: 33,077 shares worth $6.93M.
  • Dorsey Wright & Associates added most to Rollins in Q1 2019, an estimated $2.98M increase.
  • Dorsey Wright & Associates's biggest Q1 2019 reduction was Boeing, cutting an estimated $7.79M.
  • Dorsey Wright & Associates fully exited State Street SPDR S&P 500 ETF Trust in Q1 2019, selling an estimated $8.84M.
  • Dorsey Wright & Associates's ten largest holdings make up 17% of its $414M portfolio in Q1 2019.
  • Dorsey Wright & Associates opened 91 new positions and closed 70 in Q1 2019.
  • Dorsey Wright & Associates's portfolio value rose 24% quarter-over-quarter to $414M.

Based on Dorsey Wright & Associates's 13F filing for Q1 2019, filed 4 Apr 2019.